PREEMIE Reauthorization Act of 2025
The PREEMIE Reauthorization Act of 2025 reauthorizes and strengthens federal efforts to reduce prematurity and improve outcomes for preterm and low birthweight infants. It extends the authorization period to fiscal years 2025 through 2029, updates cross-references, and requires more proactive interagency coordination within the Department of Health and Human Services. It also directs the National Academies of Sciences, Engineering, and Medicine to convene a committee within 30 days to study prematurity in the U.S., produce a consensus report within 24 months, and include detailed data and analysis. The study must assess costs to society, factors that influence preterm birth rates, and opportunities for earlier detection and support across hospital and community settings, as well as evaluate research strategies, best practices, and precision medicine approaches to prevent premature birth. In short, the bill not only renews funding but also imposes concrete timetables and an independent, data-driven study to guide future policy and program decisions on prematurity, maternal health, and infant care.
Key Points
- 1Reauthorizes PREEMIE through fiscal years 2025–2029 (extends prior authorization period for research and education on prematurity and related outcomes).
- 2Technical corrections to ensure correct cross-references within PREEMIE-related law and sections.
- 3Strengthened interagency coordination: the Secretary of Health and Human Services must establish an interagency working group within 18 months of enactment.
- 4National Academies study on preterm births: convene a committee within 30 days, produce a consensus report, share a data-inclusive report with the Secretary and key congressional committees within 24 months.
- 5Study topics and analysis: assess the financial and societal costs of prematurity, factors affecting preterm birth rates, opportunities for earlier detection and support (in-hospital, non-hospital, and post-discharge); analyze targeted research strategies, state/best-practice programs, and precision medicine approaches from early life through adulthood.